| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.80e-05 | 188 | 7 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.24e-03 | 156 | 7 | 2 | GO:0019838 | |
| GeneOntologyMolecularFunction | cytokine binding | 1.26e-03 | 157 | 7 | 2 | GO:0019955 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.64e-03 | 749 | 7 | 3 | GO:0005509 | |
| GeneOntologyMolecularFunction | heparin binding | 1.87e-03 | 192 | 7 | 2 | GO:0008201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.71e-03 | 891 | 7 | 3 | GO:0005198 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 3.60e-03 | 268 | 7 | 2 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 5.19e-03 | 323 | 7 | 2 | GO:1901681 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.12e-05 | 656 | 7 | 4 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.16e-05 | 658 | 7 | 4 | GO:0030312 | |
| GeneOntologyCellularComponent | platelet alpha granule | 4.05e-04 | 93 | 7 | 2 | GO:0031091 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 5.26e-04 | 530 | 7 | 3 | GO:0062023 | |
| GeneOntologyCellularComponent | basement membrane | 6.96e-04 | 122 | 7 | 2 | GO:0005604 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.19e-02 | 519 | 7 | 2 | GO:0009897 | |
| Domain | TSP_1 | 4.08e-09 | 63 | 7 | 4 | PF00090 | |
| Domain | TSP1_rpt | 4.64e-09 | 65 | 7 | 4 | IPR000884 | |
| Domain | TSP1 | 4.64e-09 | 65 | 7 | 4 | PS50092 | |
| Domain | TSP1 | 4.64e-09 | 65 | 7 | 4 | SM00209 | |
| Domain | TSP_3 | 1.20e-06 | 5 | 7 | 2 | PF02412 | |
| Domain | Thrombospondin_3-like_rpt | 1.20e-06 | 5 | 7 | 2 | IPR003367 | |
| Domain | TSP3 | 1.20e-06 | 5 | 7 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.20e-06 | 5 | 7 | 2 | PS51236 | |
| Domain | - | 1.20e-06 | 5 | 7 | 2 | 4.10.1080.10 | |
| Domain | TSP_type-3_rpt | 1.20e-06 | 5 | 7 | 2 | IPR028974 | |
| Domain | Thrombospondin_C | 1.20e-06 | 5 | 7 | 2 | IPR008859 | |
| Domain | TSP_C | 1.20e-06 | 5 | 7 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 1.20e-06 | 5 | 7 | 2 | IPR017897 | |
| Domain | EGF_CA | 3.26e-06 | 86 | 7 | 3 | PF07645 | |
| Domain | EGF_CA | 9.34e-06 | 122 | 7 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 9.80e-06 | 124 | 7 | 3 | IPR001881 | |
| Domain | TSPN | 3.03e-05 | 23 | 7 | 2 | SM00210 | |
| Domain | VWC | 4.53e-05 | 28 | 7 | 2 | PF00093 | |
| Domain | EGF | 6.63e-05 | 235 | 7 | 3 | SM00181 | |
| Domain | EGF_3 | 6.63e-05 | 235 | 7 | 3 | PS50026 | |
| Domain | VWFC_1 | 7.54e-05 | 36 | 7 | 2 | PS01208 | |
| Domain | EGF-like_dom | 7.88e-05 | 249 | 7 | 3 | IPR000742 | |
| Domain | VWC | 8.41e-05 | 38 | 7 | 2 | SM00214 | |
| Domain | VWFC_2 | 8.41e-05 | 38 | 7 | 2 | PS50184 | |
| Domain | EGF_1 | 8.45e-05 | 255 | 7 | 3 | PS00022 | |
| Domain | EGF-like_CS | 9.06e-05 | 261 | 7 | 3 | IPR013032 | |
| Domain | EGF_2 | 9.48e-05 | 265 | 7 | 3 | PS01186 | |
| Domain | VWF_dom | 1.03e-04 | 42 | 7 | 2 | IPR001007 | |
| Domain | Laminin_G | 1.97e-04 | 58 | 7 | 2 | IPR001791 | |
| Domain | - | 5.29e-04 | 95 | 7 | 2 | 2.60.120.200 | |
| Domain | EGF | 9.27e-04 | 126 | 7 | 2 | PF00008 | |
| Domain | ConA-like_dom | 2.76e-03 | 219 | 7 | 2 | IPR013320 | |
| Domain | - | 2.35e-02 | 663 | 7 | 2 | 2.60.40.10 | |
| Domain | Ig-like_fold | 2.64e-02 | 706 | 7 | 2 | IPR013783 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.95e-07 | 39 | 5 | 3 | MM15165 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.95e-07 | 39 | 5 | 3 | M27417 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.07e-06 | 68 | 5 | 3 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.45e-06 | 109 | 5 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.70e-06 | 111 | 5 | 3 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.01e-05 | 143 | 5 | 3 | M27275 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.36e-05 | 30 | 5 | 2 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 4.36e-05 | 30 | 5 | 2 | MM15812 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 5.29e-05 | 33 | 5 | 2 | M277 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 5.37e-05 | 250 | 5 | 3 | M27554 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 9.04e-05 | 43 | 5 | 2 | M39565 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 9.43e-05 | 302 | 5 | 3 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.18e-04 | 326 | 5 | 3 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.33e-04 | 339 | 5 | 3 | M39736 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.59e-04 | 57 | 5 | 2 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.65e-04 | 58 | 5 | 2 | M2049 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.14e-04 | 66 | 5 | 2 | M18 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.47e-04 | 84 | 5 | 2 | M7098 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 3.64e-04 | 86 | 5 | 2 | M2642 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 4.53e-04 | 96 | 5 | 2 | M27792 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.05e-04 | 532 | 5 | 3 | M27870 | |
| Pathway | WP_FOCAL_ADHESION | 1.70e-03 | 187 | 5 | 2 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 1.93e-03 | 199 | 5 | 2 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.93e-03 | 199 | 5 | 2 | M7253 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 2.72e-03 | 237 | 5 | 2 | M27786 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.33e-03 | 300 | 5 | 2 | M610 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 8.19e-03 | 1389 | 5 | 3 | MM15307 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 8.27e-03 | 418 | 5 | 2 | MM15587 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 9.72e-03 | 1475 | 5 | 3 | M19806 | |
| Pubmed | 6.95e-10 | 75 | 7 | 4 | 20637190 | ||
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 3.47e-08 | 2 | 7 | 2 | 16181801 | |
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 3.47e-08 | 2 | 7 | 2 | 15037577 | |
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 38339060 | ||
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 3.47e-08 | 2 | 7 | 2 | 10027393 | |
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 17620335 | ||
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 33372257 | ||
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 21762961 | ||
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 30928339 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 3.47e-08 | 2 | 7 | 2 | 23660684 | |
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 9694593 | ||
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 39122122 | ||
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 34425286 | ||
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 12213711 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 3.47e-08 | 2 | 7 | 2 | 22930728 | |
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 17143334 | ||
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 3.47e-08 | 2 | 7 | 2 | 33759165 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 3.47e-08 | 2 | 7 | 2 | 8126073 | |
| Pubmed | 3.47e-08 | 2 | 7 | 2 | 33981184 | ||
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 3.47e-08 | 2 | 7 | 2 | 12358136 | |
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 3.47e-08 | 2 | 7 | 2 | 18594557 | |
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 3.47e-08 | 2 | 7 | 2 | 1712771 | |
| Pubmed | Reduced expression of thrombospondins and craniofacial dysmorphism in mice overexpressing Fra1. | 1.04e-07 | 3 | 7 | 2 | 16598380 | |
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 26241338 | ||
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 9373030 | ||
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 27513329 | ||
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 1.04e-07 | 3 | 7 | 2 | 18787106 | |
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 15347840 | ||
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 30939949 | ||
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 18032585 | ||
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 18178577 | ||
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 25976449 | ||
| Pubmed | Interactions between CD47 and thrombospondin reduce inflammation. | 1.04e-07 | 3 | 7 | 2 | 17442977 | |
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 19004835 | ||
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 1.04e-07 | 3 | 7 | 2 | 8400410 | |
| Pubmed | Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase. | 1.04e-07 | 3 | 7 | 2 | 8463250 | |
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 31092423 | ||
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 19818485 | ||
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 1.04e-07 | 3 | 7 | 2 | 12482844 | |
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 1.04e-07 | 3 | 7 | 2 | 1459996 | |
| Pubmed | 1.04e-07 | 3 | 7 | 2 | 33069367 | ||
| Pubmed | Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology. | 1.04e-07 | 3 | 7 | 2 | 26168731 | |
| Pubmed | EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins. | 1.04e-07 | 3 | 7 | 2 | 17638877 | |
| Pubmed | 2.08e-07 | 4 | 7 | 2 | 12909644 | ||
| Pubmed | 2.08e-07 | 4 | 7 | 2 | 19147503 | ||
| Pubmed | 2.08e-07 | 4 | 7 | 2 | 11980922 | ||
| Pubmed | 2.08e-07 | 4 | 7 | 2 | 10900205 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 2.08e-07 | 4 | 7 | 2 | 6338048 | |
| Pubmed | 2.08e-07 | 4 | 7 | 2 | 20847111 | ||
| Pubmed | 2.08e-07 | 4 | 7 | 2 | 18089612 | ||
| Pubmed | 3.47e-07 | 5 | 7 | 2 | 30622267 | ||
| Pubmed | 3.47e-07 | 5 | 7 | 2 | 23806329 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 9.72e-07 | 8 | 7 | 2 | 24460873 | |
| Pubmed | 1.25e-06 | 9 | 7 | 2 | 1371115 | ||
| Pubmed | Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program. | 3.16e-06 | 14 | 7 | 2 | 28729362 | |
| Pubmed | 7.46e-06 | 210 | 7 | 3 | 16537572 | ||
| Pubmed | 1.51e-05 | 30 | 7 | 2 | 22171010 | ||
| Pubmed | 2.06e-05 | 35 | 7 | 2 | 35858542 | ||
| Pubmed | Myh10 deficiency leads to defective extracellular matrix remodeling and pulmonary disease. | 4.58e-05 | 52 | 7 | 2 | 30389913 | |
| Pubmed | 5.91e-05 | 59 | 7 | 2 | 21421844 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 6.53e-05 | 62 | 7 | 2 | 28344315 | |
| Pubmed | 6.96e-05 | 64 | 7 | 2 | 22261194 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.26e-04 | 86 | 7 | 2 | 28327460 | |
| Interaction | THBS2 interactions | 1.76e-05 | 19 | 7 | 2 | int:THBS2 | |
| Interaction | MMP9 interactions | 2.26e-04 | 67 | 7 | 2 | int:MMP9 | |
| Interaction | THBS3 interactions | 2.76e-04 | 74 | 7 | 2 | int:THBS3 | |
| Interaction | PPP1R21 interactions | 2.84e-04 | 75 | 7 | 2 | int:PPP1R21 | |
| Interaction | MMP2 interactions | 3.81e-04 | 87 | 7 | 2 | int:MMP2 | |
| Interaction | THBS1 interactions | 8.10e-04 | 127 | 7 | 2 | int:THBS1 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 3.36e-06 | 11 | 7 | 2 | M566 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.30e-05 | 191 | 7 | 3 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.41e-05 | 196 | 7 | 3 | M3008 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 1.83e-05 | 25 | 7 | 2 | M47986 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 2.65e-05 | 30 | 7 | 2 | M47990 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC | 3.22e-05 | 33 | 7 | 2 | M11654 | |
| Coexpression | NABA_CORE_MATRISOME | 3.67e-05 | 270 | 7 | 3 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 3.88e-05 | 275 | 7 | 3 | M5884 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 4.05e-05 | 37 | 7 | 2 | M16643 | |
| Coexpression | NABA_MATRISOME | 6.93e-05 | 1008 | 7 | 4 | MM17056 | |
| Coexpression | NABA_MATRISOME | 7.43e-05 | 1026 | 7 | 4 | M5889 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 1.04e-04 | 59 | 7 | 2 | M47993 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.04e-04 | 59 | 7 | 2 | M47989 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 1.15e-04 | 62 | 7 | 2 | M1576 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 1.22e-04 | 64 | 7 | 2 | MM671 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP | 2.06e-04 | 83 | 7 | 2 | M17951 | |
| Coexpression | ZHU_CMV_24_HR_DN | 2.11e-04 | 84 | 7 | 2 | M4065 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 2.48e-04 | 91 | 7 | 2 | M40180 | |
| Coexpression | ZHU_CMV_ALL_DN | 4.23e-04 | 119 | 7 | 2 | M14555 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 4.37e-04 | 121 | 7 | 2 | M12828 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TREG_DN | 4.52e-04 | 123 | 7 | 2 | M8953 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 4.59e-04 | 124 | 7 | 2 | M7876 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 5.20e-04 | 132 | 7 | 2 | MM470 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 5.20e-04 | 132 | 7 | 2 | MM465 | |
| Coexpression | GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP | 5.52e-04 | 136 | 7 | 2 | M8939 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 5.65e-04 | 681 | 7 | 3 | M39175 | |
| Coexpression | GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN | 6.35e-04 | 146 | 7 | 2 | M6812 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 8.90e-04 | 173 | 7 | 2 | M2385 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 9.42e-04 | 178 | 7 | 2 | M17079 | |
| Coexpression | WANG_CISPLATIN_RESPONSE_AND_XPC_UP | 1.02e-03 | 185 | 7 | 2 | M19511 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 1.05e-03 | 188 | 7 | 2 | MM1071 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP | 1.08e-03 | 191 | 7 | 2 | M8671 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 1.09e-03 | 854 | 7 | 3 | M1533 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.12e-03 | 194 | 7 | 2 | M39122 | |
| Coexpression | GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP | 1.13e-03 | 195 | 7 | 2 | M9527 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN | 1.14e-03 | 196 | 7 | 2 | M9590 | |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | 1.14e-03 | 196 | 7 | 2 | M4514 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP | 1.19e-03 | 200 | 7 | 2 | M7764 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.19e-03 | 200 | 7 | 2 | M5930 | |
| Coexpression | GSE2585_THYMIC_DC_VS_MTEC_DN | 1.19e-03 | 200 | 7 | 2 | M6283 | |
| Coexpression | GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN | 1.19e-03 | 200 | 7 | 2 | M9854 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKTCELL_DN | 1.19e-03 | 200 | 7 | 2 | M4788 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 1.21e-03 | 202 | 7 | 2 | M38982 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | 1.22e-03 | 888 | 7 | 3 | MM1018 | |
| Coexpression | WINTER_HYPOXIA_METAGENE | 1.74e-03 | 243 | 7 | 2 | M14072 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 2.15e-03 | 270 | 7 | 2 | M19432 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 2.21e-03 | 274 | 7 | 2 | M289 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN | 2.32e-03 | 281 | 7 | 2 | M7089 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 2.37e-03 | 284 | 7 | 2 | MM987 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.15e-05 | 22 | 7 | 2 | gudmap_kidney_P0_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.60e-05 | 32 | 7 | 2 | gudmap_kidney_adult_RenalCapsule_k1_1000 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 5.20e-05 | 34 | 7 | 2 | gudmap_kidney_P2_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 5.73e-05 | 778 | 7 | 4 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 6.30e-05 | 797 | 7 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_500 | 7.22e-05 | 40 | 7 | 2 | gudmap_kidney_P0_CapMes_Crym_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.79e-04 | 373 | 7 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.98e-04 | 66 | 7 | 2 | gudmap_kidney_P2_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_500 | 2.42e-04 | 73 | 7 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 2.43e-04 | 414 | 7 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.56e-04 | 75 | 7 | 2 | gudmap_kidney_P1_CapMes_Crym_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 2.57e-04 | 422 | 7 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.85e-04 | 437 | 7 | 3 | GSM777046_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.28e-04 | 85 | 7 | 2 | gudmap_kidney_P0_CapMes_Crym_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.36e-04 | 86 | 7 | 2 | GSM777055_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100 | 3.36e-04 | 86 | 7 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.44e-04 | 87 | 7 | 2 | GSM777050_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.44e-04 | 466 | 7 | 3 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.10e-04 | 95 | 7 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500 | 5.00e-04 | 105 | 7 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k2 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_200 | 6.97e-04 | 124 | 7 | 2 | gudmap_kidney_P0_CapMes_Crym_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 7.31e-04 | 127 | 7 | 2 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.89e-04 | 132 | 7 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k4 | |
| CoexpressionAtlas | gallbladder | 9.90e-04 | 148 | 7 | 2 | gallbladder | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.00e-03 | 149 | 7 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_200 | 1.21e-03 | 164 | 7 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 1.23e-03 | 165 | 7 | 2 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 1.33e-03 | 740 | 7 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.44e-03 | 761 | 7 | 3 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_top-relative-expression-ranked_200 | 1.49e-03 | 182 | 7 | 2 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.52e-03 | 184 | 7 | 2 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 1.62e-03 | 793 | 7 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 1.63e-03 | 795 | 7 | 3 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 1.68e-03 | 803 | 7 | 3 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 1.69e-03 | 804 | 7 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | 1.78e-03 | 819 | 7 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.81e-03 | 201 | 7 | 2 | Arv_EB-LF_1000_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | 1.98e-03 | 849 | 7 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.15e-03 | 219 | 7 | 2 | gudmap_developingGonad_e16.5_ovary_1000_k5 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.24e-08 | 197 | 7 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.77e-06 | 168 | 7 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.11e-06 | 178 | 7 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-06 | 180 | 7 | 3 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-06 | 180 | 7 | 3 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 183 | 7 | 3 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 183 | 7 | 3 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 183 | 7 | 3 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.33e-06 | 184 | 7 | 3 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.37e-06 | 185 | 7 | 3 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 186 | 7 | 3 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.44e-06 | 187 | 7 | 3 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-06 | 188 | 7 | 3 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.56e-06 | 190 | 7 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.56e-06 | 190 | 7 | 3 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.60e-06 | 191 | 7 | 3 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.60e-06 | 191 | 7 | 3 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.64e-06 | 192 | 7 | 3 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.69e-06 | 193 | 7 | 3 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.69e-06 | 193 | 7 | 3 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.73e-06 | 194 | 7 | 3 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.73e-06 | 194 | 7 | 3 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-06 | 197 | 7 | 3 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | P03-Mesenchymal-myocytic_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.86e-06 | 197 | 7 | 3 | 079db904a08743b3c555cb7b3f5fb5c978dde25a | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.86e-06 | 197 | 7 | 3 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-06 | 197 | 7 | 3 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-06 | 198 | 7 | 3 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.90e-06 | 198 | 7 | 3 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.90e-06 | 198 | 7 | 3 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-06 | 198 | 7 | 3 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.90e-06 | 198 | 7 | 3 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.90e-06 | 198 | 7 | 3 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-06 | 198 | 7 | 3 | 7d2fe57e0f9311ac1e6854402ebc154306eb1ba5 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.94e-06 | 199 | 7 | 3 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.94e-06 | 199 | 7 | 3 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.94e-06 | 199 | 7 | 3 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-06 | 200 | 7 | 3 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.99e-06 | 200 | 7 | 3 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-06 | 200 | 7 | 3 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-06 | 200 | 7 | 3 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-06 | 200 | 7 | 3 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.99e-06 | 200 | 7 | 3 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Tacr3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.21e-04 | 109 | 7 | 2 | 92ab514fd8d6711f55de9671fc80da22b20ad248 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 113 | 7 | 2 | ec4b89e727e1b921b9cb17443774955b95814dd4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-04 | 118 | 7 | 2 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.42e-04 | 118 | 7 | 2 | 702548d8187d54e8814375e5ae7609631fc71d5f | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 119 | 7 | 2 | 8a3f0a3ed9f80d7b061162e9fa519bb09804a86c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 119 | 7 | 2 | 938da0fe90372709048bf4e5503cc1cbf8376b17 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 119 | 7 | 2 | a3807e738d7ca8cf80aa4bd35e3ee4357b1dc00f | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 134 | 7 | 2 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.83e-04 | 134 | 7 | 2 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-04 | 136 | 7 | 2 | 8f5682422ba0b477c1e0700212948457f106cb10 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.91e-04 | 137 | 7 | 2 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 137 | 7 | 2 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.91e-04 | 137 | 7 | 2 | d37f425b13bc046baa1f8619b98a16b936f88ff6 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.91e-04 | 137 | 7 | 2 | 306b11b3b9e5fd562d845fb5eaa4ac982864efce | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 139 | 7 | 2 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 139 | 7 | 2 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-04 | 140 | 7 | 2 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.00e-04 | 140 | 7 | 2 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.11e-04 | 144 | 7 | 2 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.14e-04 | 145 | 7 | 2 | 37580218f6a6f65a1d827cbcf59465f8827f9a55 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-04 | 147 | 7 | 2 | c5913cc351577e54536dd239a33e5f7a5cb79672 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D175|Adult / Lineage, Cell type, age group and donor | 2.23e-04 | 148 | 7 | 2 | 012845b10850bbc67814da247ee5a69f6d631eaa | |
| ToppCell | droplet-Heart-4Chambers-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 149 | 7 | 2 | 38890ddde0979977c8350f01497f1245ab51641a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.26e-04 | 149 | 7 | 2 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.26e-04 | 149 | 7 | 2 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.39e-04 | 153 | 7 | 2 | 65641cc82883716dba0fefb749a30174a63f4da5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.45e-04 | 155 | 7 | 2 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 156 | 7 | 2 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.48e-04 | 156 | 7 | 2 | 45a05c7a45a3ec8551818ab67f18b3b9553934c1 | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 157 | 7 | 2 | e6846ffd1bb18bf0469bc6d49ab6cf3533d9cde6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-04 | 158 | 7 | 2 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.58e-04 | 159 | 7 | 2 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.64e-04 | 161 | 7 | 2 | a60ef3f390f56bb05b687b17986fe6382f69f260 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.67e-04 | 162 | 7 | 2 | 0bdb1e5ba33e162bec1acb28256c1405a7658ee5 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.67e-04 | 162 | 7 | 2 | 5799a602ef8d83925907e8e34532428be7330228 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-04 | 163 | 7 | 2 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-04 | 163 | 7 | 2 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.74e-04 | 164 | 7 | 2 | ec68954fc09b6850273b5e59caa6b09d02151097 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.74e-04 | 164 | 7 | 2 | 6a41a159134e605b80d5e731f9ed5bc803bb531b | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.74e-04 | 164 | 7 | 2 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.77e-04 | 165 | 7 | 2 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.81e-04 | 166 | 7 | 2 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 2.84e-04 | 167 | 7 | 2 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 169 | 7 | 2 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 169 | 7 | 2 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 169 | 7 | 2 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.98e-04 | 171 | 7 | 2 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-04 | 173 | 7 | 2 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-04 | 175 | 7 | 2 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 175 | 7 | 2 | 787ac1a12cda10af5c8830471702a4cbaf43e79e | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-04 | 175 | 7 | 2 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.15e-04 | 176 | 7 | 2 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 176 | 7 | 2 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.15e-04 | 176 | 7 | 2 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 176 | 7 | 2 | eb63eb2c301e785196ccadac74a2940b2c524c62 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-04 | 177 | 7 | 2 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.19e-04 | 177 | 7 | 2 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | facs-Lung-Endomucin|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-04 | 178 | 7 | 2 | 363e523233b1800a4c8e14c7b1a7814b8da29ccd | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.26e-04 | 50 | 4 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 3.75e-05 | 31 | 7 | 2 | ctd:C577942 | |
| Drug | biphenylene | 4.52e-05 | 34 | 7 | 2 | CID000009214 | |
| Drug | Val-Val | 5.97e-05 | 39 | 7 | 2 | CID000107475 | |
| Drug | 1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea | 9.08e-05 | 48 | 7 | 2 | ctd:C581572 | |
| Drug | Nor 3 | 9.86e-05 | 50 | 7 | 2 | CID009578441 | |
| Drug | GSK1210151A | 1.07e-04 | 52 | 7 | 2 | ctd:C568713 | |
| Drug | AC1LCVWJ | 1.83e-04 | 68 | 7 | 2 | CID000657027 | |
| Drug | chondroitin sulfate | 1.96e-04 | 413 | 7 | 3 | CID000024766 | |
| Drug | K00051 | 1.99e-04 | 71 | 7 | 2 | CID009549278 | |
| Drug | TMPyP | 2.53e-04 | 80 | 7 | 2 | CID000004234 | |
| Drug | lactofen | 2.59e-04 | 81 | 7 | 2 | CID000062276 | |
| Drug | diethyl malate | 2.93e-04 | 86 | 7 | 2 | ctd:C058705 | |
| Drug | Gold Sodium Thiomalate | 3.35e-04 | 92 | 7 | 2 | ctd:D006052 | |
| Drug | Rgds Peptide | 4.44e-04 | 106 | 7 | 2 | CID000107775 | |
| Drug | trypanothione disulfide | 7.73e-04 | 140 | 7 | 2 | CID000115098 | |
| Drug | LMWH | 7.88e-04 | 663 | 7 | 3 | CID000000772 | |
| Drug | Phosgene | 1.04e-03 | 163 | 7 | 2 | ctd:D010705 | |
| Drug | Furosemide | 1.06e-03 | 164 | 7 | 2 | ctd:D005665 | |
| Drug | Etoposide [33419-42-0]; Up 200; 6.8uM; HL60; HG-U133A | 1.10e-03 | 167 | 7 | 2 | 1626_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.27e-03 | 180 | 7 | 2 | 2937_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.34e-03 | 185 | 7 | 2 | 2215_UP | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.37e-03 | 187 | 7 | 2 | 3002_UP | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 1.40e-03 | 189 | 7 | 2 | 2695_UP | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.46e-03 | 193 | 7 | 2 | 2899_UP | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 3844_UP | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.49e-03 | 195 | 7 | 2 | 3843_UP | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 2373_DN | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; HL60; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 2741_UP | |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 3331_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.50e-03 | 196 | 7 | 2 | 4169_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 5664_UP | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 2177_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.52e-03 | 197 | 7 | 2 | 6830_UP | |
| Drug | raloxifene hydrochloride; Down 200; 0.1uM; ssMCF7; HG-U133A | 1.54e-03 | 198 | 7 | 2 | 376_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; HL60; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 2472_UP | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.54e-03 | 198 | 7 | 2 | 3831_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 4990_UP | |
| Drug | Felbinac [5728-52-9]; Up 200; 18.8uM; HL60; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 3061_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; PC3; HT_HG-U133A | 1.55e-03 | 199 | 7 | 2 | 4595_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; HL60; HT_HG-U133A | 1.57e-03 | 200 | 7 | 2 | 3130_UP | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.57e-03 | 200 | 7 | 2 | 4173_UP | |
| Drug | Raloxifene Hydrochloride | 1.66e-03 | 857 | 7 | 3 | ctd:D020849 | |
| Drug | Rgd Peptide | 2.23e-03 | 239 | 7 | 2 | CID000104802 | |
| Disease | Microangiopathy, Diabetic | 5.78e-06 | 16 | 7 | 2 | C0025945 | |
| Disease | Diabetic Angiopathies | 5.78e-06 | 16 | 7 | 2 | C0011875 | |
| Disease | Sezary Syndrome | 1.69e-05 | 27 | 7 | 2 | C0036920 | |
| Disease | COVID-19 (is_marker_for) | 9.36e-05 | 63 | 7 | 2 | DOID:0080600 (is_marker_for) | |
| Disease | vital capacity | 2.26e-03 | 1236 | 7 | 3 | EFO_0004312 | |
| Disease | Mammary Neoplasms, Human | 6.25e-03 | 525 | 7 | 2 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 6.25e-03 | 525 | 7 | 2 | C4704874 | |
| Disease | Mammary Neoplasms | 6.30e-03 | 527 | 7 | 2 | C1458155 | |
| Disease | Breast Carcinoma | 6.56e-03 | 538 | 7 | 2 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HGHWSDWSSWSPCSR | 586 | Q8TE57 | |
| CPVDGSWGSWHSWSQ | 4811 | Q96RW7 | |
| SWGSWHSWSQCSASC | 4816 | Q96RW7 | |
| HWSEWSHPIHWGSNT | 236 | P31785 | |
| AASSWWDVHSSPGSW | 176 | P0CG40 | |
| GGWSHWSPWSSCSVT | 436 | P07996 | |
| QDGGWSHWSPWSSCS | 436 | P35442 | |
| EPGGSCWAHHWCAAW | 131 | O14686 |